|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Cardiology Research Laboratory, Lawson Health Research Institute, London Health Sciences Centre, Departments of Medicine, Physiology, and Pharmacology, University of Western Ontario, London, Ontario, Canada N6A 4G5
We recently demonstrated that mice
deficient in endothelial nitric oxide (NO) synthase (eNOS) have
congenital septal defects and postnatal heart failure. However, the
mechanisms by which eNOS affects heart development are not clear. We
hypothesized that deficiency in eNOS impairs myocardial angiogenesis.
Myocardial capillary densities were measured morphometrically in
neonatal mouse hearts. In vitro tube formation on Matrigel was
investigated in cardiac endothelial cells. In vivo myocardial
angiogenesis was performed by implanting Matrigel in the left
ventricular myocardium. Myocardial capillary densities and
VEGF mRNA expression were decreased in neonatal
eNOS
/
compared with neonatal wild-type mice
(P < 0.01). Furthermore, in vitro tube formation from
cardiac endothelial cells and in vivo myocardial angiogenesis were
attenuated in eNOS
/
compared with wild-type mice
(P < 0.01). In vitro tube formation was inhibited by
NG-nitro-L-arginine methyl ester in
wild-type mice and restored by a NO donor, diethylenetriamine-NO, in
eNOS
/
mice (P < 0.05). In conclusion,
deficiency in eNOS decreases VEGF expression and impairs myocardial
angiogenesis and capillary development. Decreased myocardial
angiogenesis may contribute to cardiac abnormalities during heart
development in eNOS
/
mice.
heart; endothelial cells; vascular endothelial growth factor; knockout mice; capillary development
This article has been cited by other articles:
![]() |
F.-L. Xiang, X. Lu, L. Hammoud, P. Zhu, P. Chidiac, J. Robbins, and Q. Feng Cardiomyocyte-Specific Overexpression of Human Stem Cell Factor Improves Cardiac Function and Survival After Myocardial Infarction in Mice Circulation, September 22, 2009; 120(12): 1065 - 1074. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Makino, O. Platoshyn, J. Suarez, J. X.-J. Yuan, and W. H. Dillmann Downregulation of connexin40 is associated with coronary endothelial cell dysfunction in streptozotocin-induced diabetic mice Am J Physiol Cell Physiol, July 1, 2008; 295(1): C221 - C230. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Viita, J. Markkanen, E. Eriksson, M. Nurminen, K. Kinnunen, M. Babu, T. Heikura, S. Turpeinen, S. Laidinen, T. Takalo, et al. 15-Lipoxygenase-1 Prevents Vascular Endothelial Growth Factor A- and Placental Growth Factor-Induced Angiogenic Effects in Rabbit Skeletal Muscles via Reduction in Growth Factor mRNA Levels, NO Bioactivity, and Downregulation of VEGF Receptor 2 Expression Circ. Res., February 1, 2008; 102(2): 177 - 184. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Genis, P. Gonzalo, A. S. Tutor, B. G. Galvez, A. Martinez-Ruiz, C. Zaragoza, S. Lamas, K. Tryggvason, S. S. Apte, and A. G. Arroyo Functional interplay between endothelial nitric oxide synthase and membrane type 1 matrix metalloproteinase in migrating endothelial cells Blood, October 15, 2007; 110(8): 2916 - 2923. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Hammoud, F. Xiang, X. Lu, F. Brunner, K. Leco, and Q. Feng Endothelial nitric oxide synthase promotes neonatal cardiomyocyte proliferation by inhibiting tissue inhibitor of metalloproteinase-3 expression Cardiovasc Res, July 15, 2007; 75(2): 359 - 368. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Suzuki Microvascular angioadaptation after endurance training with L-arginine supplementation in rat heart and hindleg muscles Exp Physiol, September 1, 2005; 90(5): 763 - 771. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Milkiewicz, O. Hudlicka, M. D. Brown, and H. Silgram Nitric oxide, VEGF, and VEGFR-2: interactions in activity-induced angiogenesis in rat skeletal muscle Am J Physiol Heart Circ Physiol, July 1, 2005; 289(1): H336 - H343. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Janssens, P. Pokreisz, L. Schoonjans, M. Pellens, P. Vermeersch, M. Tjwa, P. Jans, M. Scherrer-Crosbie, M. H. Picard, Z. Szelid, et al. Cardiomyocyte-Specific Overexpression of Nitric Oxide Synthase 3 Improves Left Ventricular Performance and Reduces Compensatory Hypertrophy After Myocardial Infarction Circ. Res., May 14, 2004; 94(9): 1256 - 1262. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Ni, P. Moulin, P. Gianello, O. Feron, J.-L. Balligand, and O. Devuyst Mice that Lack Endothelial Nitric Oxide Synthase Are Protected against Functional and Structural Modifications Induced by Acute Peritonitis J. Am. Soc. Nephrol., December 1, 2003; 14(12): 3205 - 3216. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Ou, Z. Ou, D. G. McCarver, R. N. Hines, K. T. Oldham, A. W. Ackerman, and K. A. Pritchard Jr. Trichloroethylene Decreases Heat Shock Protein 90 Interactions with Endothelial Nitric Oxide Synthase: Implications for Endothelial Cell Proliferation Toxicol. Sci., May 1, 2003; 73(1): 90 - 97. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |